N-Q 1 bcgnq.htm NQ~ BLUE CHIP GROWTH FUND T. Rowe Price Blue Chip Growth Fund, Inc. - 9/30/07 NQ
ITEM 1. SCHEDULE OF INVESTMENTS


T. ROWE PRICE BLUE CHIP GROWTH FUND     
Unaudited    September 30, 2007 
Portfolio of Investments   Shares  Value 
(Cost and value in $000s)     
 
COMMON STOCKS 100.0%     

CONSUMER DISCRETIONARY 10.4%
 
   

Diversified Consumer Services 0.1%
 
   
Apollo Group, Class A (1)  250,000  15,038 
    15,038 
Hotels, Restaurants & Leisure 2.9%     
International Game Technology  860,000  37,066 
Las Vegas Sands (1)  334,000  44,562 
Marriott, Class A  1,900,000  82,593 
McDonald's  500,000  27,235 
MGM Mirage (1)  550,000  49,192 
Wynn Resorts  770,000  121,321 
    361,969 
Internet & Catalog Retail 2.1%     
Amazon.com (1)  2,750,000  256,163 
    256,163 
Media 1.1%     
Discovery Holding, Series A (1)  640,000  18,464 
Grupo Televisa, ADR  820,000  19,819 
McGraw-Hill  100,000  5,091 
Omnicom  1,200,000  57,708 
Shaw Communications, B Shares  910,000  22,605 
Viacom, Class B (1)  370,000  14,419 
    138,106 
Multiline Retail 2.6%     
Kohl's (1)  2,950,000  169,123 
Target  2,375,000  150,979 
    320,102 
Specialty Retail 0.8%     
Bed Bath & Beyond (1)  1,305,400  44,540 
Home Depot  1,500,000  48,660 
    93,200 
Textiles, Apparel & Luxury Goods 0.8%     
Coach (1)  2,200,000  103,994 
    103,994 
Total Consumer Discretionary    1,288,572 

CONSUMER STAPLES 4.2%
 
   

Beverages 0.5%
 
   
PepsiCo  910,000  66,667 
    66,667 
Food & Staples Retailing 2.4%     
CVS Caremark  5,750,000  227,872 
Sysco  400,000  14,236 
Wal-Mart  1,400,000  61,110 
    303,218 
Household Products 1.3%     
Procter & Gamble  2,200,000  154,748 
    154,748 
Total Consumer Staples    524,633 

ENERGY 8.5%
 
   

Energy Equipment & Services 5.8%
 
   
Baker Hughes  1,720,000  155,437 
Schlumberger  3,250,000  341,250 
Smith International  3,100,000  221,340 
    718,027 
Oil, Gas & Consumable Fuels 2.7%     
EOG Resources  100,000  7,233 
ExxonMobil  1,500,000  138,840 
Murphy Oil  1,300,000  90,857 
Sunoco  10,000  708 
Total, ADR  1,180,000  95,615 
    333,253 
 
Total Energy    1,051,280 

FINANCIALS 16.5%
 
   
 
Capital Markets 10.2%     
Ameriprise Financial  1,045,000  65,950 
Bank of New York Mellon  1,400,000  61,796 
Charles Schwab  5,140,000  111,024 
Franklin Resources  1,460,000  186,150 
Goldman Sachs  778,000  168,624 
Legg Mason  210,000  17,701 
Merrill Lynch  725,000  51,678 
Morgan Stanley  2,350,000  148,050 
Northern Trust  1,600,000  106,032 
State Street  3,220,000  219,475 
UBS (CHF)  2,350,000  126,031 
    1,262,511 
Commercial Banks 0.6%     
Wells Fargo  2,000,000  71,240 
    71,240 
Consumer Finance 1.5%     
American Express  2,860,000  169,798 
Discover Financial (1)  925,000  19,240 
    189,038 
Diversified Financial Services 1.6%     
Citigroup  2,800,000  130,676 
CME Group  113,000  66,371 
IntercontinentalExchange (1)  10,000  1,519 
    198,566 
Insurance 2.6%     
American International Group  2,300,000  155,595 
Hartford Financial Services  437,000  40,444 
Prudential Financial  1,310,000  127,830 
    323,869 
Thrifts & Mortgage Finance 0.0%     
Countrywide Financial  250,000  4,752 
    4,752 
Total Financials    2,049,976 

HEALTH CARE 16.6%
 
   

Biotechnology 3.8%
 
   
Celgene (1)  1,700,000  121,227 
Genentech (1)  2,100,000  163,842 
Gilead Sciences (1)  4,460,000  182,280 
    467,349 
Health Care Equipment & Supplies 3.7%     
Alcon  491,000  70,665 
Baxter International  550,000  30,954 
Medtronic  2,725,000  153,717 
St. Jude Medical (1)  2,325,000  102,463 
Stryker  1,300,000  89,388 
Zimmer Holdings (1)  140,000  11,338 
    458,525 
Health Care Providers & Services 5.3%     
Aetna  2,480,000  134,590 
Cardinal Health  740,000  46,272 
Express Scripts (1)  1,300,000  72,566 
Humana (1)  900,000  62,892 
Laboratory Corporation of America (1)  730,000  57,108 
Medco (1)  1,030,000  93,102 
UnitedHealth Group  1,300,000  62,959 
WellPoint (1)  1,700,000  134,164 
    663,653 
Life Sciences Tools & Services 0.2%     
Thermo Fisher Scientific (1)  460,000  26,551 
    26,551 
Pharmaceuticals 3.6%     
Allergan  1,500,000  96,705 
Eli Lilly  610,000  34,727 
Merck  1,510,000  78,052 
Novartis (CHF)  100,000  5,505 
Roche Holding - Genusscheine (CHF)  520,000  94,043 
Schering-Plough  3,070,000  97,104 
Wyeth  910,000  40,541 
    446,677 
 
Total Health Care    2,062,755 

INDUSTRIALS & BUSINESS SERVICES 10.2%
 
   

Aerospace & Defense 2.3%
 
   
General Dynamics  1,870,000  157,959 
Lockheed Martin  55,000  5,967 
Rockwell Collins  575,000  41,998 
United Technologies  910,000  73,236 
    279,160 
Air Freight & Logistics 0.3%     
Expeditors International of Washington  880,000  41,624 
    41,624 

Construction & Engineering 0.8%
 
   
Foster Wheeler (1)  700,000  91,896 
    91,896 
Industrial Conglomerates 4.1%     
GE  10,850,000  449,190 
McDermott International (1)  1,100,000  59,488 
    508,678 
Machinery 2.7%     
Danaher  3,350,000  277,079 
Illinois Tool Works  1,030,000  61,429 
    338,508 
Total Industrials & Business Services    1,259,866 

INFORMATION TECHNOLOGY 26.7%
 
   

Communications Equipment 6.4%
 
   
Cisco Systems (1)  7,750,000  256,602 
Corning  2,660,000  65,569 
Juniper Networks (1)  5,200,000  190,372 
LM Ericsson (SEK)  12,225,000  48,707 
Nokia, ADR  4,075,000  154,565 
Qualcomm  1,850,000  78,181 
    793,996 
Computers & Peripherals 4.1%     
Apple (1)  1,519,000  233,228 
Dell (1)  3,130,000  86,388 
EMC (1)  4,750,000  98,800 
Hewlett-Packard  1,090,000  54,271 
Network Appliance (1)  1,375,000  37,001 
    509,688 

Internet Software & Services 3.9%
 
   
eBay (1)  3,130,000  122,133 
Google, Class A (1)  568,000  322,209 
Monster Worldwide (1)  1,240,000  42,234 
    486,576 
IT Services 1.7%     
Accenture, Class A  1,450,000  58,363 
Automatic Data Processing  3,100,000  142,383 
Mastercard, Class A  70,000  10,358 
    211,104 
Semiconductor & Semiconductor Equipment 5.1%     
Analog Devices  2,200,000  79,552 
Applied Materials  100,000  2,070 
ASML Holding, ADS (1)  2,000,000  65,720 
Broadcom, Class A (1)  740,000  26,966 
Intel  4,150,000  107,319 
Marvell Technology Group (1)  5,900,000  96,583 
Maxim Integrated Products  2,100,000  61,635 
Texas Instruments  2,500,000  91,475 
Xilinx  3,740,000  97,763 
    629,083 
Software 5.5%     
Adobe Systems (1)  1,500,000  65,490 
Autodesk (1)  1,720,000  85,948 
Electronic Arts (1)  1,900,000  106,381 
Intuit (1)  1,600,000  48,480 
Microsoft  9,350,000  275,451 
Oracle (1)  4,250,000  92,013 
    673,763 
 
Total Information Technology    3,304,210 

MATERIALS 2.2%
 
   

Chemicals 1.2%
 
   
Monsanto  1,670,000  143,186 
    143,186 
Metals & Mining 1.0%     
Freeport McMoRan Copper Gold  1,180,000  123,770 
    123,770 
Total Materials    266,956 

TELECOMMUNICATION SERVICES 4.7%
 
   

Diversified Telecommunication Services 0.6%
 
   
AT&T  1,850,000  78,273 
    78,273 
Wireless Telecommunication Services 4.1%     
America Movil, ADR, Series L  2,860,000  183,040 
American Tower Systems, Class A (1)  3,850,000  167,629 
Bharti Airtel (INR) (1)  700,000  16,884 
MetroPCS Communications (1)  890,000  24,279 
Rogers Communications, Class B  2,500,000  113,825 
    505,657 
Total Telecommunication Services    583,930 
 
Total Common Stocks (Cost $8,603,759)    12,392,178 

SHORT-TERM INVESTMENTS 0.1%
 
   

Money Market Funds 0.1%
 
   
T. Rowe Price Reserve Investment Fund, 5.46% (2)(3)  16,005,003  16,005 
Total Short-Term Investments (Cost $16,005)    16,005 

Total Investments in Securities
 
   
100.1% of Net Assets (Cost $8,619,764)  $  12,408,183 


 
       
  Denominated in U.S. dollars unless otherwise noted. 
(1)  Non-income producing 
(2)  Seven-day yield 
(3)  Affiliated company - see Note 3. 
ADR  American Depository Receipts 
ADS  American Depository Shares 
CHF  Swiss Franc 
INR  Indian Rupee 
SEK  Swedish Krona 



The accompanying notes are an integral part of this Portfolio of Investments.

 


T. Rowe Price Blue Chip Growth Fund   
Unaudited  September 30, 2007 
Notes To Portfolio of Investments   

NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES

T. Rowe Price Blue Chip Growth Fund, Inc. (the fund), is registered under the Investment Company Act of 1940 (the 1940 Act) as a diversified, open-end management investment company. The fund seeks to provide long-term capital growth. Income is a secondary objective.

The accompanying portfolio of investments was prepared in accordance with accounting principles generally accepted in the United States of America, which require the use of estimates made by fund management. Fund management believes that estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the portfolio of investments may differ from the value the fund receives upon sale of the securities.

Valuation

The fund values its investments and computes its net asset value per share at the close of the New York Stock Exchange (NYSE), normally 4 p.m. ET, each day that the NYSE is open for business. Equity securities listed or regularly traded on a securities exchange or in the over-the-counter (OTC) market are valued at the last quoted sale price or, for certain markets, the official closing price at the time the valuations are made, except for OTC Bulletin Board securities, which are valued at the mean of the latest bid and asked prices. A security that is listed or traded on more than one exchange is valued at the quotation on the exchange determined to be the primary market for such security. Listed securities not traded on a particular day are valued at the mean of the latest bid and asked prices for domestic securities and the last quoted sale price for international securities.

Investments in mutual funds are valued at the mutual fund’s closing net asset value per share on the day of valuation.

Other investments, including restricted securities, and those for which the above valuation procedures are inappropriate or are deemed not to reflect fair value are stated at fair value as determined in good faith by the T. Rowe Price Valuation Committee, established by the fund’s Board of Directors.

Most foreign markets close before the close of trading on the NYSE. If the fund determines that developments between the close of a foreign market and the close of the NYSE will, in its judgment, materially affect the value of some or all of its portfolio securities, which in turn will affect the fund’s share price, the fund will adjust the previous closing prices to reflect the fair value of the securities as of the close of the NYSE, as determined in good faith by the T. Rowe Price Valuation Committee, established by the fund’s Board of Directors. A fund may also fair value securities in other situations, such as when a particular foreign market is closed but the fund is open. In deciding whether to make fair value adjustments, the fund reviews a variety of factors, including developments in foreign markets, the performance of U.S. securities markets, and the performance of instruments trading in U.S. markets that represent foreign securities and baskets of foreign securities. The fund uses outside pricing services to provide it with closing market prices and information used for adjusting those prices. The fund cannot predict when and how often it will use closing prices and when it will adjust those prices to reflect fair value. As a means of evaluating its fair value process, the fund routinely compares closing market prices, the next day’s opening prices in the same markets, and adjusted prices.

Investment Transactions

Investment transactions are accounted for on the trade date.

New Accounting Pronouncement

In September 2006, the Financial Accounting Standards Board (FASB) released the Statement of Financial Accounting Standard No. 157 (FAS 157), Fair Value Measurements. FAS 157 clarifies the definition of fair value and establishes the framework for measuring fair value, as well as proper disclosure of this methodology in the financial statements. It will be effective for the fund’s fiscal year beginning January 1, 2008. Management is evaluating the effects of FAS 157; however, it is not expected to have a material impact on the fund’s net assets or results of operations.

NOTE 2 - FEDERAL INCOME TAXES

At September 30, 2007, the cost of investments for federal income tax purposes was $8,619,764,000. Net unrealized gain aggregated $3,788,492,000 at period-end, of which $3,869,162,000 related to appreciated investments and $80,670,000 related to depreciated investments.

NOTE 3 - RELATED PARTY TRANSACTIONS

The fund may invest in the T. Rowe Price Reserve Investment Fund and the T. Rowe Price Government Reserve Investment Fund (collectively, the T. Rowe Price Reserve Investment Funds), open-end management investment companies managed by Price Associates and affiliates of the fund. The T. Rowe Price Reserve Investment Funds are offered as cash management options to mutual funds, trusts, and other accounts managed by Price Associates and/or its affiliates, and are not available for direct purchase by members of the public. The T. Rowe Price Reserve Investment Funds pay no investment management fees. During the nine months ended September 30, 2007, dividend income from the T. Rowe Price Reserve Investment Funds totaled $1,748,000, and the value of shares of the T. Rowe Price Reserve Investment Funds held at September 30, 2007, and December 31, 2006, was $16,005,000 and $12,545,000 respectively.




Item 2. Controls and Procedures.

(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-Q was recorded, processed, summarized, and reported timely.

(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3. Exhibits.

Separate certifications by the registrant's principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.




SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

T. Rowe Price Blue Chip Growth Fund, Inc.

By  /s/ Edward C. Bernard 
  Edward C. Bernard 
  Principal Executive Officer 
 
Date  November 16, 2007 

     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By  /s/ Edward C. Bernard 
  Edward C. Bernard 
  Principal Executive Officer 
 
Date  November 16, 2007 

By  /s/ Joseph A. Carrier 
  Joseph A. Carrier 
  Principal Financial Officer 
 
Date  November 16, 2007